Tibet Aim Pharm Inc (002826) — Cash Flow Quality Index
Tibet Aim Pharm Inc (002826) has a Cash Flow Quality Index of 1.98x as of September 2025. Operating cash flow of CN¥87.55 Million exceeds net income of CN¥44.21 Million, indicating high earnings quality where cash backs reported profits. Explore 002826 strategic capital deployment ratio to see how much of total assets are deployed in long-term investments.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Tibet Aim Pharm Inc Cash Flow Quality Index (2013–2025)
Historical Cash Flow Quality Index for Tibet Aim Pharm Inc across 13 annual periods. Values consistently above 1.0x indicate high-quality earnings. Check how tangible is Tibet Aim Pharm Inc's equity to evaluate the tangible quality of the company's equity base.
Annual Cash Flow Quality Index for Tibet Aim Pharm Inc (2013–2025)
Year-by-year earnings quality comparison for Tibet Aim Pharm Inc. For live market cap and the full company financial profile, see market value of Tibet Aim Pharm Inc.
| Year | Quality Index | Operating CF (CNY) | Net Income | YoY Change |
|---|---|---|---|---|
| 2025 | 1.34x | CN¥123.72 Million | CN¥92.58 Million | ▼ -43.2% |
| 2024 | 2.35x | CN¥111.57 Million | CN¥47.46 Million | ▼ -78.3% |
| 2023 | 10.85x | CN¥166.88 Million | CN¥15.39 Million | ▲ +630.7% |
| 2022 | 1.48x | CN¥68.45 Million | CN¥46.12 Million | ▼ -41.1% |
| 2021 | 2.52x | CN¥109.52 Million | CN¥43.47 Million | ▲ +1.8% |
| 2020 | 2.48x | CN¥101.74 Million | CN¥41.09 Million | ▲ +56.1% |
| 2019 | 1.59x | CN¥59.20 Million | CN¥37.33 Million | ▲ +200.8% |
| 2018 | 0.53x | CN¥13.31 Million | CN¥25.26 Million | ▼ -58.7% |
| 2017 | 1.28x | CN¥77.29 Million | CN¥60.48 Million | ▲ +23.7% |
| 2016 | 1.03x | CN¥57.18 Million | CN¥55.36 Million | ▲ +274.0% |
| 2015 | -0.59x | CN¥-29.69 Million | CN¥50.03 Million | ▼ -1019.9% |
| 2014 | 0.06x | CN¥2.18 Million | CN¥33.86 Million | ▼ -97.3% |
| 2013 | 2.39x | CN¥52.24 Million | CN¥21.82 Million | — |